Our CEO, Susan Wood, was recently interviewed by the Nuance team about LungPrint and the AI market in general. See the full interview on the What's Next Blog by Nuance.
VIDA provides personalized care solutions that can help pulmonologists identify specific disease phenotypes as well as decide on the most appropriate treatments
